Baxter International, Inc. (BAX)
23.80
-0.38
(-1.57%)
USD |
NYSE |
Sep 11, 16:00
23.81
+0.01
(+0.04%)
After-Hours: 20:00
Baxter International Market Cap : 12.30B for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 12.30B |
| September 10, 2026 | 12.50B |
| September 09, 2026 | 12.61B |
| September 08, 2026 | 12.85B |
| September 04, 2026 | 13.35B |
| September 03, 2026 | 13.22B |
| September 02, 2026 | 13.29B |
| September 01, 2026 | 13.17B |
| August 31, 2026 | 13.44B |
| August 28, 2026 | 13.51B |
| August 27, 2026 | 13.41B |
| August 26, 2026 | 13.70B |
| August 25, 2026 | 13.59B |
| August 24, 2026 | 13.70B |
| August 21, 2026 | 13.62B |
| August 20, 2026 | 13.65B |
| August 19, 2026 | 13.77B |
| August 18, 2026 | 13.41B |
| August 17, 2026 | 13.40B |
| August 14, 2026 | 13.82B |
| August 13, 2026 | 13.98B |
| August 12, 2026 | 13.93B |
| August 11, 2026 | 14.27B |
| August 10, 2026 | 14.36B |
| August 07, 2026 | 14.24B |
| Date | Value |
|---|---|
| August 06, 2026 | 13.96B |
| August 05, 2026 | 14.13B |
| August 04, 2026 | 14.66B |
| August 03, 2026 | 14.53B |
| July 31, 2026 | 13.52B |
| July 30, 2026 | 13.83B |
| July 29, 2026 | 12.81B |
| July 28, 2026 | 12.60B |
| July 27, 2026 | 12.07B |
| July 24, 2026 | 11.58B |
| July 23, 2026 | 11.20B |
| July 22, 2026 | 11.24B |
| July 21, 2026 | 11.48B |
| July 20, 2026 | 11.41B |
| July 17, 2026 | 11.69B |
| July 16, 2026 | 12.07B |
| July 15, 2026 | 11.45B |
| July 14, 2026 | 11.27B |
| July 13, 2026 | 11.67B |
| July 10, 2026 | 11.69B |
| July 09, 2026 | 11.61B |
| July 08, 2026 | 11.36B |
| July 07, 2026 | 11.82B |
| July 06, 2026 | 11.67B |
| July 02, 2026 | 11.71B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Becton, Dickinson & Co. | 48.44B |
| DexCom, Inc. | 31.34B |
| Boston Scientific Corp. | 62.18B |
| West Pharmaceutical Services, Inc. | 24.37B |
| Abbott Laboratories | 176.41B |
Market Cap Related Metrics
| PS Ratio | 1.069 |
| PEG Ratio | -0.0197 |
| Price to Book Value | 1.983 |
| Price to Free Cash Flow | 15.10 |
| Price | 23.80 |
| Earnings Yield | -8.10% |
| PEGY Ratio | -0.0197 |
| Operating PE Ratio | 19.01 |